AHAS1: A pilot trial to determine whether reduced dose intravenous Abciximab achieves optimal platelet inhibition in acute ischemic stroke "AHAS1"

Recruiting

Phase N/A Results N/A

Summary of Purpose

to determine platelet inhibition with our dosing protocol and its relationship to complications and outcomes.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 8 March 2010.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Veterans Affairs Medical Center

Trial Design

Not available

Contacts

Not available